rs41721

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001061.7(TBXAS1):​c.1134+4164T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.785 in 152,018 control chromosomes in the GnomAD database, including 47,269 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.79 ( 47269 hom., cov: 32)

Consequence

TBXAS1
NM_001061.7 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.95

Publications

4 publications found
Variant links:
Genes affected
TBXAS1 (HGNC:11609): (thromboxane A synthase 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostglandin H2 to thromboxane A2, a potent vasoconstrictor and inducer of platelet aggregation. The enzyme plays a role in several pathophysiological processes including hemostasis, cardiovascular disease, and stroke. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
TBXAS1 Gene-Disease associations (from GenCC):
  • ghosal hematodiaphyseal dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001061.7, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.857 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001061.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBXAS1
NM_001061.7
MANE Select
c.1134+4164T>C
intron
N/ANP_001052.3P24557-1
TBXAS1
NM_001166253.4
c.1272+4164T>C
intron
N/ANP_001159725.2P24557-3
TBXAS1
NM_001130966.5
c.1134+4164T>C
intron
N/ANP_001124438.2P24557-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBXAS1
ENST00000448866.7
TSL:1 MANE Select
c.1134+4164T>C
intron
N/AENSP00000402536.3P24557-1
TBXAS1
ENST00000336425.10
TSL:1
c.1134+4164T>C
intron
N/AENSP00000338087.7P24557-1
TBXAS1
ENST00000425687.5
TSL:1
c.933+4164T>C
intron
N/AENSP00000388736.1P24557-2

Frequencies

GnomAD3 genomes
AF:
0.786
AC:
119323
AN:
151900
Hom.:
47249
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.678
Gnomad AMI
AF:
0.932
Gnomad AMR
AF:
0.829
Gnomad ASJ
AF:
0.862
Gnomad EAS
AF:
0.878
Gnomad SAS
AF:
0.781
Gnomad FIN
AF:
0.762
Gnomad MID
AF:
0.769
Gnomad NFE
AF:
0.832
Gnomad OTH
AF:
0.789
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.785
AC:
119372
AN:
152018
Hom.:
47269
Cov.:
32
AF XY:
0.782
AC XY:
58107
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.678
AC:
28026
AN:
41360
American (AMR)
AF:
0.830
AC:
12696
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.862
AC:
2990
AN:
3470
East Asian (EAS)
AF:
0.878
AC:
4547
AN:
5178
South Asian (SAS)
AF:
0.779
AC:
3759
AN:
4824
European-Finnish (FIN)
AF:
0.762
AC:
8055
AN:
10570
Middle Eastern (MID)
AF:
0.776
AC:
228
AN:
294
European-Non Finnish (NFE)
AF:
0.832
AC:
56559
AN:
67992
Other (OTH)
AF:
0.786
AC:
1664
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1281
2563
3844
5126
6407
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
868
1736
2604
3472
4340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.818
Hom.:
32222
Bravo
AF:
0.784
Asia WGS
AF:
0.789
AC:
2740
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.14
DANN
Benign
0.66
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs41721;
hg19: chr7-139666196;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.